Please login to the form below
Open Access Consulting
This page shows the latest Open Access Consulting news and features for those working in and with pharma, biotech and healthcare.
OPEN Health unveils restructuring
Previously known as Accretio, OPEN Health Consulting will be headed up by Accretio’s managing director Richard Baderin. ... OPEN VIE, the company’s Value, Informatics and Evidence functions (previously known as OPEN Access Consulting, Harvey Walsh
Latest news
-
OPEN Health launches market access division
The healthcare communications group OPEN Health has launched a dedicated market access division to be called OPEN Access Consulting. ... The new managing directors also explained that OPEN Access Consulting will work with other division of OPEN Health,
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Open Access Consulting appoints new director
Jayne Hurrell joins the group from Evidera. Open Access Consulting, part of the Open Health Group, has appointed Jayne Hurrell into the newly created role of director of global value communications. ... evidence. Commenting on the appointment, Dorinda
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
- Congress is in session – how companies are boosting their impact and engagement
PMHub
Thrive Agency
We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
